Compound Tropicamide Eye Drops

This product is composed of tropicamide and phenylephrine hydrochloride. Tropicamide has atropine-like parasympathetic nerve inhibitory effect, which can cause mydriasis and accommodation paralysis after drug absorption, while phenylephrine hydrochloride has sympathetic nerve excitatory effect, which manifests as mydriasis and local vasoconstriction after absorption.

Each bottle contains 25 mg of tropicamide and 25 mg of phenylephrine hydrochloride.

Compound tropicamide eye drops (Medoly) is a colorless or slightly yellow clear liquid.

Mydriatic drugs. Mydriatic and accommodative paralytic drugs for examination.

1. Mydriasis examination: drop the drug into the conjunctival sac, 1 drop at a time, and drop it again after 5 minutes. 2. Refractive examination: drop the drug into the conjunctival sac, once every 5 minutes, for 4 times in a row, and do a refractive examination after 20 minutes.

Occasionally, local eye irritation symptoms may occur. It may also cause a temporary slight increase in intraocular pressure in patients with open-angle glaucoma, but since phenylephrine itself has the effect of lowering intraocular pressure, it will not cause damage to the optic nerve.

It is contraindicated in patients with unoperated angle-closure glaucoma.

Precautions for children: Since systemic adverse reactions are prone to occur when used by children, they should be fully observed and used with caution. In particular, there have been reports of bradycardia and respiratory arrest in premature infants. They should be fully observed and use should be stopped immediately if abnormalities are found. Appropriate treatment is recommended. The best method is to dilute the product before use as needed. Precautions for pregnancy and lactation: It should only be used when its therapeutic benefits outweigh the risks. The safety of medication during pregnancy is not yet clear. Precautions for the elderly: Generally, the physiological functions of the elderly are reduced, and attention should be paid.

Concomitant use with monoamine oxidase inhibitors or tricyclic antidepressants can cause a significant increase in blood pressure.

Keep away from light, tightly closed, in a cool place.

1 ml: Tropicamide 5 mg, Phenylephrine HCl 5 mg

24 months

Shenyang XINGQI Pharmaceutical Co., Ltd.

• Founded in:

  1977-03-24

• Address:

  No. 25, Xinyunhe Road, Shenyang Area, China (Liaoning) Pilot Free Trade Zone

• Tax NO.:

  912101001179988209

• Registered Funds:

  124.589194 yuan

• Website:

  Log in to view

• Email:

  Log in to view